Sujal Shah - Director at Tvardi Therapeutics, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Issuer context
SEC evidence

There are no Buy or Sell transactions made by Sujal Shah since 31 May 2025

Holdings reported by Sujal Shah for Tvardi Therapeutics, Inc.

Form 4 holding Director

Tvardi Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
12,000
Estimated value
Report date
17 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Sujal Shah for Tvardi Therapeutics, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .